Intuitive Surgical (ISRG -3.2%) slips after a cautious mention on Twitter by Citron Research,...


Intuitive Surgical (ISRG -3.2%) slips after a cautious mention on Twitter by Citron Research, saying hospitals are beginning to question the value of robotic surgery. The tweet links to an article in the Monterey Herald that infers ISRG's da Vinci system is nothing more than "razzle-dazzle marketing," and questions whether the $2m price tag is justified.

From other sites
Comments (1)
  • Charlieboy Stevens
    , contributor
    Comments (84) | Send Message
     
    AS WITH MOST SURGERIES, THE FINAL COST IS CALCULATED BY MANY FACTORS BEYOND THE SURGICAL COST. VERY CLEARLY, THESE AFTER SURGERY COSTS ARE MUCH LOWER WHEN THE DA VINCI ROBOTIC OPERATING MACHINE IS USED BECAUSE HEALING IS MUCH FASTER. THIS ROBOTIC METHOD PORVIDED BY INTUITIVE SURGERICAL'S ROBOTIC DA VINCI MACHINE IS CLEARLY SUPERIOR THAN ALL ALTERNATIVES. ALL THIS IS FULLY SUPPORTED BY ALL AVAILABLE DATA. CWS.
    4 Mar 2013, 03:16 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs